2. Gene
  3. C5 - complement C5 Gene

C5 - complement C5 Gene

  • Gene
  • Protein
  • Disease
  • Agent
  • Ortholog
Homo sapiens

Also known as C5D; C5a; C5b; ECLZB; CPAMD4

Gene ID: 727 | Gene type: protein coding

About C5

Cytogenetic location: 9q33.2 Genomic coordinates (GRCh38): 9:120,952,335-121,074,865 (from NCBI)

This gene has 13 transcripts (splice variants), 196 orthologues, 8 paralogues and is associated with 3 phenotypes. Biased expression in liver (RPKM 85.9) and lung (RPKM 3.7).

Summary

This gene encodes a component of the Complement System, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase Enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause Complement Component 5 deficiency, a disease characterized by recurrent Bacterial infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]

C5 Products(3)

mRNA Protein Name
NM_001317163.2 NP_001304092.1 complement C5 isoform 2
NM_001317164.2 NP_001304093.1 complement C5 isoform 3 precursor
NM_001735.3 NP_001726.2 complement C5 isoform 1 preproprotein

C5 Protein Structure

A2M_N

A2M_N: MG2 domain (126 - 219)

A2M_N_2

A2M_N_2: Alpha-2-macroglobulin family N-terminal region (473 - 610)

ANATO

ANATO: Anaphylotoxin-like domain (698 - 732)

A2M

A2M: Alpha-2-macroglobulin family (772 - 859)

A2M_comp

A2M_comp: A-macroglobulin complement component (1052 - 1301)

A2M_recep

A2M_recep: A-macroglobulin receptor (1419 - 1509)

NTR

NTR: UNC-6/NTR/C345C module (1551 - 1658)

  • 0
  • 300
  • 600
  • 900
  • 1200
  • 1500
  • 1676 a.a.
Protein Preferred Names Protein Names

complement C5

C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4

Recombinant C5 Proteins

Cat. No. Product Name Accession Purity
HY-P7864 Complement C5/C5a Protein, Human P01031 (T678-R751) ≥95%
HY-P700862 Complement C5/C5a Protein, Human (HEK293, His) P01031-1 (Q19-C1676) ≥95%
HY-P700959 Complement C5/C5a Protein, Human (His) P01031 (T678-R751) ≥95%

Related Diseases

Diseases Alias
Complement Component 5 Deficiency

C5 Deficiency

C5D
Eculizumab, Poor Response To
Leiner Disease

Erythroderma Desquamativum

Complement Component 5 Deficiency
Immunodeficiency Due To A Late Component Of Complement Deficiency

Immunodeficiency Due To C5 To C9 Component Complement Deficiency

Terminal Complement Pathway Deficiency
Complement Deficiency

Complement Deficiency Disease

Hereditary Complement Deficiency Diseases
Acute Poststreptococcal Glomerulonephritis

Post-Streptococcal Glomerulonephritis

Acute Post-Streptococcal Glomerulonephritis
Hemoglobinuria
Hemolytic-Uremic Syndrome

Hemolytic Uremic Syndrome

Haemolytic-Uraemic Syndrome

Hus

Acute Renal Failure, Thrombocytopenia, And Microangiopathic Hemolytic Anemia Associated With Distorted Erythrocytes

Typical Haemolytic Uraemic Syndrome

Gasser Syndrome

Hus - [Haemolytic Uraemic Syndrome]
Meningoencephalitis

Acquired Toxoplasmal Meningoencephalitis

Meningoencephalitis Due To Acquired Toxoplasmosis

Meningoencephalitis Due To Toxoplasmosis

Toxoplasma Meningoencephalitis
Hellp Syndrome

Hemolysis, Elevated Liver Enzymes, Lowered Platelets

Hemolysis, Elevated Liver Enzymes, Low Platelets In Pregnancy

Hemolysis-Elevated Liver Enzymes-Low Platelets Syndrome

Hellp - [Syndrome Of Haemolysis, Elevated Liver Enzymes And Low Platelet]

Haemolysis-Elevated Liver Enzymes-Low Platelet Count Syndrome
Hemolytic Uremic Syndrome, Atypical 1

Atypical Hemolytic-Uremic Syndrome

Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 1

Atypical Hemolytic Uremic Syndrome

Hemolytic Uremic Syndrome, Atypical, Susceptibility To

Ahus

AHUS1

Hemolytic-Uremic Syndrome

Ahus 1

Ahus, Susceptibility To, 1

Hemolytic Uremic Syndrome, Atypical

Non-Shiga-Like Toxin-Associated Hus

Non-Stx-Hus

Nonenteropathic Hus

Atypical Hus

Shiga Toxin-Associated Hemolytic Uremic Syndrome

D+ Hus

Ehec-Hus

Hemolytic Uremic Syndrome Associated With Shiga Toxin-Producing Escherichia Coli

Hemolytic Uremic Syndrome With Diarrhea

Stec-Hus

Shiga-Like Toxin-Associated Hus

Stx-Hus

Typical Hus

Typical Hemolytic Uremic Syndrome

Atypical Hemolytic Uremic Syndrome With Anti-Factor H Antibodies

Atypical Hus With Anti-Factor H Antibodies

Ahus With Anti-Factor H Antibodies

Ahus With Neutralizing Autoantibodies Against Factor H

Hemolytic Uremic Syndrome Atypical 1

Atypical Hemolytic Uremic Syndrome With H Factor Anomaly

D Hus

Hemolytic-Uremic Syndrome Without Diarrhea

Hemolytic-Uremic Syndrome, Atypical, Type 1

Hemolytic Uremic Syndrome, Typical
Systemic Lupus Erythematosus

Lupus Nephritis

SLE

Disseminated Lupus Erythematosus

Systemic Lupus Erythematosus, Susceptibility To

Lupus Erythematosus, Systemic

Lupus Nephritis, Susceptibility To

Libman-Sacks Disease

Systemic Lupus Erythematosus Susceptibility To

Sle - Lupus Erythematosus, Systemic

Le Syndrome

Lupus

Lupus Erythematosus Systemic

Lupus Erythematosus, Systemic, Susceptibility To

Lupus Vulgaris

Lupus Erythematosus, Discoid

Lupus Erythematosus

Systemic Lupus Erythematosus Nos

Sle - [Systemic Lupus Erythematosus]
Macular Degeneration, Age-Related, 1

Macular Degeneration

Age-Related Macular Degeneration

Macular Degeneration, Age-Related

Age Related Macular Degeneration

Age Related Macular Degeneration 1

ARMD1

Senile Macular Degeneration

Maculopathy, Age-Related, 1

Macular Degeneration, Age-Related, Reduced Risk Of

Age Related Maculopathy 1

Age Related Maculopathies

Age Related Maculopathy

Senile Macular Retinal Degeneration

Macular Degeneration Of Retina

Age-Related Maculopathy

Amd

Armd

Age-Related Maculopathy, Susceptibility To

Maculopathy Age-Related

Macular Degeneration, Age-Related, 1, Susceptibility To

Maculopathy, Age-Related

Macular Degeneration, Age-Related, Type 1

Macular Degeneration, Age-Related, 2
Membranoproliferative Glomerulonephritis

Mesangiocapillary Glomerulonephritis

Dense Deposit Disease

Membranoproliferative Glomerulonephritis Type 2

Primary Membranoproliferative Glomerulonephritis

Mesangiocapillary Glomerulonephritis, Type Ii

Glomerulonephritis, Membranoproliferative

Chronic Glomerulonephritis, Lobular

Lobular Glomerulonephritis

Ddd

Glomerulonephritis Membranoproliferative Type 2

Mpgn 2

Membranoproliferative Glomerulonephritis Type Ii

Mesangiocapillary Glomerulonephritis Type 2

Mpgn

Primary Mpgn

Glomerulonephritis Membranoproliferative

Membranoproliferative Glomerulonephritis, Type Ii
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

Approval
Bioactive Molecules (10)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-14541 Olanzapine 99.83% Yes
HY-11100 Asenapine maleate Antagonist 99.95% Unkown
HY-B1213 Trimipramine maleate 99.97% Unkown
HY-147080 Avacincaptad pegol sodium Inhibitor 98.53% Unkown
HY-17627 Avacopan 99.75% Yes
HY-P3502 Zilucoplan Inhibitor 95.33% Unkown
HY-16567 Asenapine hydrochloride Antagonist 99.95% Unkown
HY-148457 Avacincaptad pegol Inhibitor / Unkown
HY-14541R Olanzapine (Standard) / Unkown
HY-B1213A Trimipramine / Unkown
Inhibitory Antibodies (3)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P99394 Talquetamab 98.52% Unkown
HY-P9914 Eculizumab Inhibitor 97.81% Unkown
HY-P99365 Ravulizumab Inhibitor 95.00% Unkown
Clinical Phase
Bioactive Molecules (5)
Cat. No. Product Name Effect
Purity Phase
HY-145720 Cemdisiran Inhibitor 96.02% Phase 3
HY-101324A MK-212 monohydrochloride 99.62% Phase 3
HY-101324 MK-212 / Phase 3
HY-111200 Vabicaserin hydrochloride Agonist 99.92% Phase 2
HY-19283 DU125530 / Phase 2
Inhibitory Antibodies (8)
Cat. No. Product Name Effect
Purity Phase
HY-P99520 Vilobelimab Inhibitor 99.27% Phase 3
HY-P99786 Pozelimab Inhibitor 99.45% Phase 3
HY-P99638 Gefurulimab Inhibitor 97.88% Phase 3
HY-P99965 Crovalimab Inhibitor 98.61% Phase 3
HY-P99886 Pexelizumab Inhibitor / Phase 3
HY-P99322 Tesidolumab Inhibitor 97.01% Phase 2
HY-P99450 Avdoralimab Inhibitor 95.16% Phase 2
HY-P99767 Olendalizumab Inhibitor / Phase 2
Pre-clinical Phase
Bioactive Molecules (310)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-106178 PMX-53 Antagonist 98.60% Unkown
HY-N0390S1 L-Glutamine-13C5 ≥98.0% Unkown
HY-128729 DNA2 inhibitor C5 Inhibitor 98.51% Unkown
HY-138161 JR14a Antagonist 98.52% Unkown
HY-110136A PMX 205 Trifluoroacetate Antagonist 98.02% Unkown
HY-D1612 BODIPY FL C5-Ceramide 99.65% Unkown
HY-W008820 Glutaric acid ≥98.0% Unkown
HY-148141 JPE-1375 Antagonist 99.94% Unkown
HY-125876 PROTAC Bcl2 degrader-1 Inhibitor 98.78% Unkown
HY-149652 IRF5-IN-1 99.70% Unkown
HY-16992A W-54011 ≥98.0% Unkown
HY-122725B Lenalidomide-C5-NH2 hydrochloride 98.44% Unkown
HY-128342 Complement C5-IN-1 Inhibitor 99.01% Unkown
HY-132248 C5 Lenalidomide Inhibitor / Unkown
HY-W004710 NH2-C5-NH-Boc 99.88% Unkown
HY-Y0252S L-Proline-13C5 99.00% Unkown
HY-130798 (S,R,S)-AHPC-amido-C5-acid 99.58% Unkown
HY-N0717S6 L-Valine-13C5 ≥98.0% Unkown
HY-N0092S2 Inosine-13C5 99.90% Unkown
HY-W013636S 2-Ketoglutaric acid-13C5 ≥98.0% Unkown
HY-110060 NDT 9513727 Antagonist 99.10% Unkown
HY-141840 GLP-1R modulator C5 Modulator 99.60% Unkown
HY-14608S3 L-Glutamic acid-13C5,15N ≥98.0% Unkown
HY-N0326S5 L-Methionine-13C5 ≥98.0% Unkown
HY-131889 Thalidomide-O-C5-acid Inducer 96.24% Unkown
HY-14608S5 L-Glutamic acid-13C5 ≥98.0% Unkown
HY-151667 Biotin-C5-Azide ≥98.0% Unkown
HY-W006057AS16 Sodium 3-methyl-2-oxobutanoate-13C5 99.00% Unkown
HY-15543A CP-809101 hydrochloride Agonist 99.37% Unkown
HY-153098 ARC186 Inhibitor 94.13% Unkown
HY-B0228S1 Adenosine-13C5 99.35% Unkown
HY-B0445S NAD+-13C5 ammonium 98.89% Unkown
HY-N0390S6 L-Glutamine-13C5,15N2 ≥98.0% Unkown
HY-N0717S1 L-Valine-13C5,15N ≥98.0% Unkown
HY-R00540 hsa-miR-30c-5p mimic 94.48% Unkown
HY-RI00540 hsa-miR-30c-5p inhibitor 96.52% Unkown
HY-153785 NH2-C6-ARC186 sodium Inhibitor 92.50% Unkown
HY-130849 (S,R,S)-AHPC-Me-C5-COOH 96.19% Unkown
HY-136237 Thalidomide-NH-C5-NH2 hydrochloride Inducer 99.28% Unkown
HY-101343 RS 39604 Antagonist ≥98.0% Unkown
HY-128848 Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH 95.02% Unkown
HY-132141 5-PA-dUTP ≥98.0% Unkown
HY-14541S Olanzapine-d3 99.09% Unkown
HY-157080 Dibromomaleimide-C5-COOH 99.30% Unkown
HY-RI00334 hsa-miR-181c-5p inhibitor 97.20% Unkown
HY-W008820S1 Glutaric acid-d4 ≥99.0% Unkown
HY-129608 Lenalidomide-acetylene-C5-COOH 98.32% Unkown
HY-101755 Tedatioxetine hydrobromide Antagonist 99.98% Unkown
HY-108372 Boc-C5-O-C5-O-C6-Cl / Unkown
HY-110136 PMX 205 Antagonist / Unkown
HY-113038AS α-Hydroxyglutaric acid-13C5 disodium 99.80% Unkown
HY-113046S 5-Methyltetrahydrofolic acid-13C5 ≥98.0% Unkown
HY-126523 N3-C5-NHS ester 98.04% Unkown
HY-130703 5-Dehydroepisterol Inhibitor 92.36% Unkown
HY-131455A Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 TFA ≥98.0% Unkown
HY-132856 Lenalidomide-C5-amido-Boc 95.10% Unkown
HY-137905 Pomalidomide-amido-C5-PEG2-C6-chlorine 99.69% Unkown
HY-138848A Thalidomide-4-O-C5-NH2 hydrochloride Inducer 96.87% Unkown
HY-139336 Pomalidomide-C5-azide 97.46% Unkown
HY-148671 (S,R,S)-AHPC-amido-C7-acid 98.28% Unkown
HY-150918S 5-Methyl-1H-pyrazole-3-propanoic acid-13C5 / Unkown
HY-16637S3 Folic acid-13C5 ≥95.0% Unkown
HY-N0326S6 L-Methionine-13C5,15N 99.20% Unkown
HY-N0390S3 L-Glutamine-13C5,15N2,d5 99.91% Unkown
HY-P0014S1 Liraglutide-13C5,15N TFA / Unkown
HY-P4820A SYNV-cyclo(CGGYF) TFA Inhibitor 97.08% Unkown
HY-R00540A hsa-miR-30c-5p agomir / Unkown
HY-RI00007A hsa-let-7c-5p antagomir 93.03% Unkown
HY-RI00540A hsa-miR-30c-5p antagomir 95.34% Unkown
HY-W010184S 4,6-Dioxoheptanoic acid-13C5 ≥98.0% Unkown
HY-W096148 Biotin-C4-amide-C5-NH2 ≥97.0% Unkown
HY-Y0252S4 L-Proline-13C5,15N 99.60% Unkown
HY-135916 Biotin-C5-amino-C5-amino / Unkown
HY-B0445S1 NAD+-13C5 98.90% Unkown
HY-W028210 O-Phthalimide-C5-acid ≥98.0% Unkown
HY-122725A Lenalidomide-C5-NH2 TFA 98.94% Unkown
HY-141423 Thalidomide-O-amide-C5-NH2 Inducer / Unkown
HY-141423A Thalidomide-O-amide-C5-NH2 TFA Inducer / Unkown
HY-136055 (S,R,S)-AHPC-C5-COOH Inhibitor 98.81% Unkown
HY-103120 Org37684 Antagonist / Unkown
HY-112199 CP-447697 Antagonist 99.70% Unkown
HY-113062S 20α-Dihydroprogesterone-13C5 / Unkown
HY-124117 LY 278584 Antagonist / Unkown
HY-130712 NH2-C2-amido-C2-Boc / Unkown
HY-130946 NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 / Unkown
HY-132939 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-C5-Br Chemical / Unkown
HY-134737 Boc-NH-PEG1-C5-OH / Unkown
HY-134986 Thalidomide-NH-C5-NH2 Inducer / Unkown
HY-136187 (S,R,S)-AHPC-C5-NH2 / Unkown
HY-136187A (S,R,S)-AHPC-C5-NH2 dihydrochloride / Unkown
HY-138098 Sartorypyrone B / Unkown
HY-138848 Thalidomide-4-O-C5-NH2 Inducer / Unkown
HY-138851 Thalidomide-NH-amido-C5-NH2 Inducer / Unkown
HY-138851A Thalidomide-NH-amido-C5-NH2 hydrochloride Inducer / Unkown
HY-139996 Pomalidomide-C5-Dovitinib / Unkown
HY-141062 N-Methyl-N'-(azido-PEG2-C5)-Cy5 / Unkown
HY-141143 MC(C5)-Val-Cit / Unkown
HY-141593 Modified MMAF-C5-COOH / Unkown
HY-141902S Fmoc-Glu(OtBu)-OH-13C5,15N / Unkown
HY-14291S2 Vildagliptin-13C5,15N / Unkown
HY-143340 LEB-03-145 / Unkown
HY-144676 pan-HER-IN-1 / Unkown
HY-14608S4 L-Glutamic acid-13C5,15N,d5 / Unkown
HY-147077 Triantennary GalNAc-1 / Unkown
HY-147585 C5aR-IN-1 / Unkown
HY-147586 C5aR-IN-2 / Unkown
HY-147587 C5aR-IN-3 / Unkown
HY-14781S2 Levomefolic acid-13C5 / Unkown
HY-148326 Glu(OtBu)-Val-Cit-PAB-OH / Unkown
HY-148362 Pomalidomide-C6-O-C5-O-C4-COOH 98.55% Unkown
HY-149751 Methylthiomcresol-C5-COOH / Unkown
HY-150632 SARS-CoV-2 nsp13-IN-6 Inhibitor / Unkown
HY-150660S Ercalcidiol-13C5 / Unkown
HY-150661S 3-epi-Calcifediol-13C5 / Unkown
HY-150663S Calcitriol-13C5 / Unkown
HY-153464 CXCR4-IN-1 Inhibitor / Unkown
HY-15398S4 Vitamin D3-13C5 / Unkown
HY-155186 SARS-CoV-2 3CLpro-IN-19 Inhibitor / Unkown
HY-155261 Pomalidomide-5-C5-NH2 hydrochloride / Unkown
HY-155506 NAMPT degrader-3 Degrader / Unkown
HY-155672 JPC0323 Modulator / Unkown
HY-157511 Thalidomide-O-C5-azide / Unkown
HY-157933 SF-C5-TPP / Unkown
HY-160077 Pomalidomide-CO-C5-azide / Unkown
HY-160241 Lenalidomide-C5-acid 96.36% Unkown
HY-161132 Lenalidomide 4'-alkyl-C5-azide / Unkown
HY-163378 C5aR1 antagonist 1 Antagonist / Unkown
HY-163379 C5aR1 antagonist 2 Antagonist / Unkown
HY-16384 L-156602 Antagonist / Unkown
HY-16567S Asenapine-13C,d3 hydrochloride Antagonist / Unkown
HY-16637S2 (Rac)-Folic acid-13C5,15N / Unkown
HY-16637S4 Folic acid-13C5,15N / Unkown
HY-17383S Levomefolate-13C5 calcium Chemical / Unkown
HY-19528S1 SAH-13C5 / Unkown
HY-21994 Org-12962 hydrochloride Agonist / Unkown
HY-32351AS1 Calcifediol-13C5 monohydrate / Unkown
HY-B0152S2 Adenine-13C5,15N5 Chemical / Unkown
HY-B0152S3 Adenine-13C5 Chemical / Unkown
HY-B0389S17 D-Glucose-13C-5 / Unkown
HY-B0434S Ribavirin-13C5 Inhibitor / Unkown
HY-B0456S2 Riboflavin-13C5 / Unkown
HY-B1449S10 Uridine-13C5 / Unkown
HY-B1654S Flavin adenine dinucleotide-13C5 ammonium / Unkown
HY-D1592 BODIPY TMR C5-maleimide / Unkown
HY-D1610 BODIPY FL C5 99.68% Unkown
HY-D1611 BODIPY FL-C5 NHS Ester / Unkown
HY-D1613 BODIPY FL C5-HPC / Unkown
HY-I1111S2 Fmoc-L-Val-OH-13C5,15N Inhibitor / Unkown
HY-I1111S3 Fmoc-L-Val-OH-13C5 / Unkown
HY-N0210S4 D-Galactose-13C-5 / Unkown
HY-N0322S3 Cholesterol-13C5 Agonist / Unkown
HY-N0379S10 D-Mannose-13C-5 / Unkown
HY-N0437S1 Progesterone-13C5 Agonist / Unkown
HY-N0717S2 L-Valine-13C5,15N,d8 / Unkown
HY-N0717S3 L-Valine-13C5,15N,d2 / Unkown
HY-N12728 Heteroclitin G / Unkown
HY-N3406 Lansiumarin C / Unkown
HY-P3502A Zilucoplan TFA Inhibitor / Unkown
HY-P4820 SYNV-cyclo(CGGYF) Inhibitor / Unkown
HY-P4971 C5a Anaphylatoxin (human) Modulator / Unkown
HY-P5506 C5a Receptor agonist, mouse, human Agonist / Unkown
HY-R00007 hsa-let-7c-5p mimic / Unkown
HY-R00007A hsa-let-7c-5p agomir / Unkown
HY-R00334 hsa-miR-181c-5p mimic / Unkown
HY-R00334A hsa-miR-181c-5p agomir / Unkown
HY-R00408 hsa-miR-200c-5p mimic / Unkown
HY-R00408A hsa-miR-200c-5p agomir / Unkown
HY-R00514 hsa-miR-29c-5p mimic / Unkown
HY-R00514A hsa-miR-29c-5p agomir / Unkown
HY-R00718 hsa-miR-34c-5p mimic / Unkown
HY-R00718A hsa-miR-34c-5p agomir / Unkown
HY-R00833 hsa-miR-374c-5p mimic / Unkown
HY-R00833A hsa-miR-374c-5p agomir / Unkown
HY-R00841 hsa-miR-376c-5p mimic / Unkown
HY-R00841A hsa-miR-376c-5p agomir / Unkown
HY-R01113 hsa-miR-449c-5p mimic / Unkown
HY-R01113A hsa-miR-449c-5p agomir / Unkown
HY-R01547 hsa-miR-513c-5p mimic / Unkown
HY-R01547A hsa-miR-513c-5p agomir / Unkown
HY-R01569 hsa-miR-518c-5p mimic / Unkown
HY-R01569A hsa-miR-518c-5p agomir / Unkown
HY-R02507 hsa-miR-892c-5p mimic / Unkown
HY-R02507A hsa-miR-892c-5p agomir / Unkown
HY-R02796 mmu-miR-1970c-5p mimic / Unkown
HY-R02796A mmu-miR-1970c-5p agomir / Unkown
HY-R02834 mmu-miR-216c-5p mimic / Unkown
HY-R02834A mmu-miR-216c-5p agomir / Unkown
HY-R02841 mmu-miR-219c-5p mimic / Unkown
HY-R02841A mmu-miR-219c-5p agomir / Unkown
HY-R02883 mmu-miR-297c-5p mimic / Unkown
HY-R02883A mmu-miR-297c-5p agomir / Unkown
HY-R02898 mmu-miR-302c-5p mimic / Unkown
HY-R02898A mmu-miR-302c-5p agomir / Unkown
HY-R03044 mmu-miR-344c-5p mimic / Unkown
HY-R03044A mmu-miR-344c-5p agomir / Unkown
HY-R03105 mmu-miR-374c-5p mimic / Unkown
HY-R03105A mmu-miR-374c-5p agomir / Unkown
HY-R03112 mmu-miR-376c-5p mimic / Unkown
HY-R03112A mmu-miR-376c-5p agomir / Unkown
HY-R03149 mmu-miR-449c-5p mimic / Unkown
HY-R03149A mmu-miR-449c-5p agomir / Unkown
HY-R03164 mmu-miR-465c-5p mimic / Unkown
HY-R03164A mmu-miR-465c-5p agomir / Unkown
HY-R03171 mmu-miR-466c-5p mimic / Unkown
HY-R03171A mmu-miR-466c-5p agomir / Unkown
HY-R03199 mmu-miR-467c-5p mimic / Unkown
HY-R03199A mmu-miR-467c-5p agomir / Unkown
HY-R03461 mmu-miR-669c-5p mimic / Unkown
HY-R03461A mmu-miR-669c-5p agomir / Unkown
HY-R04278 rno-miR-196c-5p mimic / Unkown
HY-R04278A rno-miR-196c-5p agomir / Unkown
HY-R04285 rno-miR-200c-5p mimic / Unkown
HY-R04285A rno-miR-200c-5p agomir / Unkown
HY-R04448 rno-miR-376c-5p mimic / Unkown
HY-R04448A rno-miR-376c-5p agomir / Unkown
HY-R04485 rno-miR-466c-5p mimic / Unkown
HY-R04485A rno-miR-466c-5p agomir / Unkown
HY-RI00007 hsa-let-7c-5p inhibitor / Unkown
HY-RI00334A hsa-miR-181c-5p antagomir / Unkown
HY-RI00408 hsa-miR-200c-5p inhibitor / Unkown
HY-RI00408A hsa-miR-200c-5p antagomir / Unkown
HY-RI00514 hsa-miR-29c-5p inhibitor / Unkown
HY-RI00514A hsa-miR-29c-5p antagomir / Unkown
HY-RI00718 hsa-miR-34c-5p inhibitor / Unkown
HY-RI00718A hsa-miR-34c-5p antagomir / Unkown
HY-RI00833 hsa-miR-374c-5p inhibitor / Unkown
HY-RI00833A hsa-miR-374c-5p antagomir / Unkown
HY-RI00841 hsa-miR-376c-5p inhibitor / Unkown
HY-RI00841A hsa-miR-376c-5p antagomir / Unkown
HY-RI01113 hsa-miR-449c-5p inhibitor / Unkown
HY-RI01113A hsa-miR-449c-5p antagomir / Unkown
HY-RI01547 hsa-miR-513c-5p inhibitor / Unkown
HY-RI01547A hsa-miR-513c-5p antagomir / Unkown
HY-RI01569 hsa-miR-518c-5p inhibitor / Unkown
HY-RI01569A hsa-miR-518c-5p antagomir / Unkown
HY-RI02507 hsa-miR-892c-5p inhibitor / Unkown
HY-RI02507A hsa-miR-892c-5p antagomir / Unkown
HY-RI02796 mmu-miR-1970c-5p inhibitor / Unkown
HY-RI02796A mmu-miR-1970c-5p antagomir / Unkown
HY-RI02834 mmu-miR-216c-5p inhibitor / Unkown
HY-RI02834A mmu-miR-216c-5p antagomir / Unkown
HY-RI02841 mmu-miR-219c-5p inhibitor / Unkown
HY-RI02841A mmu-miR-219c-5p antagomir / Unkown
HY-RI02883 mmu-miR-297c-5p inhibitor / Unkown
HY-RI02883A mmu-miR-297c-5p antagomir / Unkown
HY-RI02898 mmu-miR-302c-5p inhibitor / Unkown
HY-RI02898A mmu-miR-302c-5p antagomir / Unkown
HY-RI03044 mmu-miR-344c-5p inhibitor / Unkown
HY-RI03044A mmu-miR-344c-5p antagomir / Unkown
HY-RI03105 mmu-miR-374c-5p inhibitor / Unkown
HY-RI03105A mmu-miR-374c-5p antagomir / Unkown
HY-RI03112 mmu-miR-376c-5p inhibitor / Unkown
HY-RI03112A mmu-miR-376c-5p antagomir / Unkown
HY-RI03149 mmu-miR-449c-5p inhibitor / Unkown
HY-RI03149A mmu-miR-449c-5p antagomir / Unkown
HY-RI03164 mmu-miR-465c-5p inhibitor / Unkown
HY-RI03164A mmu-miR-465c-5p antagomir / Unkown
HY-RI03171 mmu-miR-466c-5p inhibitor / Unkown
HY-RI03171A mmu-miR-466c-5p antagomir / Unkown
HY-RI03199 mmu-miR-467c-5p inhibitor / Unkown
HY-RI03199A mmu-miR-467c-5p antagomir / Unkown
HY-RI03461 mmu-miR-669c-5p inhibitor / Unkown
HY-RI03461A mmu-miR-669c-5p antagomir / Unkown
HY-RI04278 rno-miR-196c-5p inhibitor / Unkown
HY-RI04278A rno-miR-196c-5p antagomir / Unkown
HY-RI04285 rno-miR-200c-5p inhibitor / Unkown
HY-RI04285A rno-miR-200c-5p antagomir / Unkown
HY-RI04448 rno-miR-376c-5p inhibitor / Unkown
HY-RI04448A rno-miR-376c-5p antagomir / Unkown
HY-RI04485 rno-miR-466c-5p inhibitor / Unkown
HY-RI04485A rno-miR-466c-5p antagomir / Unkown
HY-RS01749 C5 Human Pre-designed siRNA Set A / Unkown
HY-RS01750 C5AR1 Human Pre-designed siRNA Set A / Unkown
HY-RS01751 C5AR2 Human Pre-designed siRNA Set A / Unkown
HY-RS12597 SDR16C5 Human Pre-designed siRNA Set A / Unkown
HY-W000450S 5-Aminolevulinic acid-13C / Unkown
HY-W008371S1 Fmoc-Met-OH-13C5,15N / Unkown
HY-W008585 Benzo-15-crown-5-ether / Unkown
HY-W008820S2 Glutaric acid-d2 / Unkown
HY-W013780S1 Fmoc-Pro-OH-13C5,15N Inhibitor / Unkown
HY-W015913S4 2-Oxopropanoate-13c2 sodium / Unkown
HY-W016145S L-Glutamic acid-13C5 hydrate salt / Unkown
HY-W017018S2 L-Ornithine-1,2,3,4,5-13C5 hydrochloride / Unkown
HY-W017387S2 Alpha-ketoisocaproic acid-13C5 sodium / Unkown
HY-W017401S Benzisothiazolinone-13C5 Inhibitor / Unkown
HY-W018772S15 D-Ribose(mixture of isomers)-13C5 / Unkown
HY-W040047S Pregnanediol 3-glucuronide-13C5 / Unkown
HY-W040055S Neopterin-13C5 / Unkown
HY-W096134 Benzyloxy-C5-PEG1 / Unkown
HY-W400722 Sodium 3-methyl-2-oxobutanoate-13C5,d1 / Unkown
HY-W877850 Mal-C5-N-bis(PEG2-C2-acid) 96.25% Unkown
HY-Y0252S6 L-Proline-13C5,15N,d7 / Unkown
HY-Y0520S Itaconic acid-13C5 ≥97.00% Unkown
HY-Y1055S2 Guanine-13C5,15N5 Chemical / Unkown
HY-Y1055S4 Guanine-13C5 Chemical / Unkown
HY-112675S 4-Octyl itaconate-13C5-1 / Unkown
HY-133411A NH2-O-C5-COOH hydrobromide / Unkown
HY-143704S 5-Aminosalicylic acid-13C6 hydrochloride / Unkown
HY-144345S L-γ-Glutamyl-L-cysteinyl-L-lysine-13C5,15N / Unkown
HY-149562 Thalidomide-5-O-C5-NH2 hydrochloride / Unkown
HY-149691 O-Phthalimide-C1-S-C5-acid / Unkown
HY-15543 CP-809101 Agonist / Unkown
HY-160235 Pomalidomide-C2-amide-C5-azide / Unkown
HY-B1511S Cyclic AMP-13C5 / Unkown
HY-E70206 CpG Methyltransferase / Unkown
HY-N0091S Hypoxanthine-13C5,15N4 / Unkown
HY-N0091S2 Hypoxanthine-13C5 / Unkown
HY-P1032S1 Angiotensin I-13C5,15N (human, mouse, rat) / Unkown
HY-W039426 N-Trityl-N4-benzoyl-morpholino-C-5'-O-phosphoramidite / Unkown
HY-W728005 Covidcil-19 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Felis catus C5 VGNC VGNC:60232
Bos taurus C5 VGNC VGNC:49997
Macaca mulatta C5 VGNC VGNC:70475
Canis familiaris C5 VGNC VGNC:38595
Rattus norvegicus C5 RGD RGD:2237
Mus musculus C5 MGD MGI:96031
Macaca fascicularis C5 NCBI
Susscrofa domestica C5 NCBI
Others C5 NCBI